Indication:
Antiva® is indicated for the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
Dosage & Administration:
The recommended dose of Antiva® in chronic hepatitis B patients with adequate renal function is 10 mg, once daily, taken orally, without regard to food.
Preparation:
Antiva® Tablet: Each box contains 10 tablets in blister pack
